Model
Edge
Revance Therapeutics Inc.
0001793796
Filing Type
3
Filing Date
2/28/2024
Updated
2/29/24, 9:32 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership